6.1 Glycemic Emergencies

AACN CCRN Adult

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Strategy

1.1 Exam Facts, Format & the Synergy Model Blueprint 1.2 How to Study & Test-Taking Strategy

2 Cardiovascular I — Hemodynamics & Shock

2.1 Hemodynamic Monitoring & Values 2.2 Shock States 2.3 Vasoactive & Inotropic Pharmacology

3 Cardiovascular II — ACS, Heart Failure & Dysrhythmias

3.1 Acute Coronary Syndrome & Myocardial Infarction 3.2 Heart Failure & Mechanical Circulatory Support 3.3 Dysrhythmias, ECG & ACLS

4 Respiratory I -- Failure, ABGs & Acute Conditions

4.1 Respiratory Failure & ABG Interpretation 4.2 Acute Respiratory Distress Syndrome (ARDS) 4.3 Pulmonary Embolism, Pneumothorax, COPD & Asthma

5 Respiratory II — Mechanical Ventilation

5.1 Ventilator Modes & Settings 5.2 Weaning, Airway & Ventilator Complications

6 Endocrine Emergencies

6.1 Glycemic Emergencies 6.2 DI, SIADH, Thyroid & Adrenal Crises

7 Renal & Genitourinary

7.1 Acute Kidney Injury, Electrolytes & Acid-Base 7.2 Renal Replacement Therapy

8 Gastrointestinal

8.1 GI Bleeding & Acute Hepatic Failure 8.2 Pancreatitis, Acute Abdomen, Bowel Ischemia & Nutrition

9 Hematology, Immunology & Integumentary

9.1 Coagulopathies & Transfusion Therapy 9.2 Immunocompromise & Oncologic Emergencies 9.3 Integumentary - Wounds & Pressure Injuries

10 Neurological I — Stroke, TBI & ICP

10.1 Ischemic & Hemorrhagic Stroke 10.2 Traumatic Brain Injury & ICP Management 10.3 Seizures, Status Epilepticus & Neuromonitoring

11 Neurological II & Musculoskeletal

11.1 Spinal Cord Injury & Neuromuscular Emergencies 11.2 Encephalopathy, Coma & Brain Death 11.3 Musculoskeletal

12 Behavioral & Psychosocial

12.1 Delirium, Agitation, Sedation & Pain 12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety

13 Multisystem I — Sepsis & MODS

13.1 Sepsis & Septic Shock 13.2 Multi-Organ Dysfunction Syndrome 13.3 Resuscitation Priorities & Rapid Response

14 Multisystem II — Trauma, Burns & Toxicology

14.1 Trauma & Burns 14.2 Toxicology, Anaphylaxis & Temperature Emergencies

15 Synergy Model, Advocacy & Caring

15.1 The AACN Synergy Model 15.2 Advocacy & Moral Agency 15.3 Caring Practices

16 Collaboration, Systems Thinking & Diversity

16.1 Collaboration & Interdisciplinary Teamwork 16.2 Systems Thinking 16.3 Response to Diversity & Facilitation of Learning

17 Clinical Inquiry, Ethics & End-of-Life

17.1 Clinical Inquiry & Evidence-Based Practice 17.2 Ethical/Legal Issues, End-of-Life & Goals of Care

6.1 Glycemic Emergencies

Key Takeaways Explain This Topic AI

DKA (2024 adult consensus) is defined by glucose ≥200 mg/dL or a known history of diabetes (about 10% present with euglycemic DKA), elevated ketones (β-hydroxybutyrate ≥3.0 mmol/L), and pH <7.3 and/or serum bicarbonate <18 mEq/L; the anion gap is usually elevated.

HHS is defined by glucose >600 mg/dL, serum osmolality >320 mOsm/kg, minimal or absent ketosis, and pH >7.3 with profound dehydration.

The treatment sequence in DKA/HHS is IV isotonic fluids first, then an insulin infusion, with continuous potassium replacement guided by the K+ level.

Hold the insulin infusion if serum potassium is <3.5 mEq/L until potassium is replaced (2024 adult consensus), because insulin drives K+ intracellularly and can cause fatal hypokalemia.

Add 5-10% IV dextrose when glucose falls below 250 mg/dL so the insulin infusion continues to close the anion gap without causing hypoglycemia.

Last updated: October 2026

Diabetic Ketoacidosis (DKA)

Diabetic ketoacidosis (DKA) is an acute metabolic decompensation caused by an absolute or relative deficiency of insulin combined with a rise in counter-regulatory hormones (glucagon, catecholamines, cortisol, growth hormone). Without insulin, cells cannot use glucose, so the liver over-produces glucose and breaks down fat into free fatty acids that are converted to ketone bodies (beta-hydroxybutyrate and acetoacetate). These ketoacids drive a high anion gap metabolic acidosis . DKA is classically a complication of type 1 diabetes but can occur in type 2, and it is frequently precipitated by Infection , Insulin omission , Ischemia (MI), and Intoxication — the "4 I's" the CCRN loves to test.

Diagnostic thresholds

DKA is defined by the triad of hyperglycemia, ketosis, and acidosis:

Glucose ≥200 mg/dL or a known history of diabetes (often much higher, but about 10% present with euglycemic DKA below 200 mg/dL, for example with SGLT2 inhibitors or pregnancy)

• Arterial pH <7.3 and serum bicarbonate <18 mEq/L
• Positive serum/urine ketones (beta-hydroxybutyrate is the more sensitive test)
• Elevated anion gap (Na − [Cl + HCO3]) >10-12 mEq/L

Severity is graded mild-to-severe by pH and mental status; severe DKA has pH <7.0 and stupor/coma. Kussmaul respirations (deep, rapid breathing) represent respiratory compensation for the acidosis, and a fruity acetone odor may be present.

Managing DKA: fluids, insulin, potassium

The order of interventions is critical and is the single most tested DKA concept. Memorize the sequence: fluids first, then insulin, with potassium managed continuously.

IV fluids first. Begin with isotonic 0.9% normal saline or a balanced crystalloid at 500-1,000 mL/hr for the first 2-4 hours in adults without renal or cardiac compromise (smaller 250 mL boluses in older adults, heart failure, or dialysis) to restore intravascular volume. Volume alone lowers glucose and improves perfusion. Once corrected sodium and volume improve, switch to 0.45% saline.

Insulin infusion. Start a regular insulin infusion at roughly 0.1 unit/kg/hr (a bolus is optional and increasingly omitted). Insulin shuts off ketogenesis and closes the anion gap. The goal is to lower glucose by ~50-75 mg/dL per hour — faster drops risk cerebral edema.

Potassium replacement. Total-body potassium is always depleted even when the measured serum K+ looks normal or high, because acidosis shifts K+ out of cells. As insulin and fluids correct the acidosis, K+ moves back intracellularly and the serum level falls sharply.

The potassium safety rule

Before or during insulin therapy, check the potassium:

• Serum K+ Action
• <3.5 mEq/L Hold insulin , replace K+ first (about 10 mEq/hr) until >3.5, then start insulin
• 3.5-5.0 mEq/L Give insulin AND add 20-30 mEq K+ per liter of fluid

>5.0 mEq/L Give insulin, hold K+ until it falls below 5.0; recheck 2 hours after insulin starts, then every 4 hours

Giving insulin when K+ is <3.5 mEq/L (the 2024 adult consensus threshold) drives the remaining potassium into cells and can cause life-threatening hypokalemia and arrhythmias — a classic CCRN trap.

Adding dextrose

When the glucose falls below 250 mg/dL , add 5-10% IV dextrose to the fluids. This is counterintuitive but essential: the ketoacidosis usually has NOT yet resolved, so the insulin infusion must continue to clear ketones. Dextrose lets you keep insulin running without causing hypoglycemia. DKA is resolved when plasma ketone (β-hydroxybutyrate) is <0.6 mmol/L and venous pH is ≥7.3 or bicarbonate is ≥18 mEq/L (ideally glucose <200 mg/dL); the anion gap and urine ketones are not used as resolution criteria. A normal glucose alone does NOT mean resolution. Do not stop the IV insulin abruptly; overlap with subcutaneous insulin for 1-2 hours to prevent rebound ketosis.

Cerebral edema risk

Cerebral edema is a feared, potentially fatal complication, most common in children and adolescents but tested for all ages. It is associated with overly rapid correction of glucose and osmolality and aggressive fluid administration. Signs include worsening headache, deteriorating mental status, bradycardia, and hypertension. Prevention is measured correction; treatment is mannitol or hypertonic saline and elevating the head of bed.

Hyperosmolar Hyperglycemic State (HHS)

HHS occurs typically in older type 2 diabetics with a precipitating illness. Enough endogenous insulin is present to suppress ketogenesis, so patients do NOT develop significant acidosis, but glucose climbs to extreme levels, driving an osmotic diuresis and profound dehydration . HHS is distinguished from DKA by glucose often >600 mg/dL, serum osmolality >320 mOsm/kg, minimal/absent ketosis, and pH >7.3 . Neurologic changes (obtundation, seizures, coma) are prominent because of the marked hyperosmolality. Mortality is higher than DKA (up to 10-20%). Treatment mirrors DKA — the cornerstone is aggressive fluid resuscitation to correct the severe volume deficit (often 8-10 L), followed by a lower-rate insulin infusion and cautious potassium replacement.

Hypoglycemia

Hypoglycemia (glucose <70 mg/dL, severe <54 mg/dL) is an immediate threat to the brain. In the ICU it commonly complicates insulin infusions, sepsis, hepatic/adrenal failure, and tight glycemic control. Adrenergic signs (diaphoresis, tremor, tachycardia) give way to neuroglycopenic signs (confusion, seizures, coma). A patient on a DKA insulin infusion who becomes diaphoretic, tremulous, and confused with a glucose of 48 mg/dL needs the hypoglycemia treated first : give IV dextrose (D50) in the conscious/IV-access patient (or IM glucagon if no access), then recheck the glucose and adjust the infusion per protocol. Do not delay treatment to hunt for a cause.

Monitoring and common CCRN traps

During resuscitation, the CCRN nurse trends hourly point-of-care glucose , serial basic metabolic panels every 2-4 hours for the anion gap, potassium, and corrected sodium, and continuous ECG for hypo/hyperkalemic changes (peaked T waves, U waves). Watch for the refractory hypokalemia produced by coexisting hypomagnesemia : a chronic-alcohol patient with a magnesium of 1.0 mg/dL whose potassium will not rise despite replacement needs magnesium repleted first , because low magnesium promotes renal potassium wasting and blocks correction. Two additional traps recur on the exam. First, euglycemic DKA — driven by SGLT2 inhibitors, pregnancy, or starvation — presents with a near-normal glucose but a wide anion gap and ketosis; treat it as DKA with fluids, insulin, and early dextrose, not as a mild case. Second, the corrected sodium : hyperglycemia falsely lowers measured sodium (add ~1.6-2.0 mEq/L per 100 mg/dL of glucose above 100), so a "low" sodium may actually be normal or high, guiding your fluid choice. Finally, follow phosphate ; severe hypophosphatemia during treatment can impair respiratory muscle strength and is replaced when the level drops below ~1.0 mg/dL.